Trademark: 97235738
Status Date
Wednesday, August 23, 2023
Filing Date
Monday, January 24, 2022
Published for Opposition
Tuesday, February 21, 2023
Abandoned Date
Wednesday, August 23, 2023
5 pharmaceutical substances for use in the prevention, treatment and management of cancer, pain, mental health disorders, cancer related distress, anxiety, depression and post-traumatic stress disorder; pharmaceutical substances for use in the management of side effects from chemotherapy, radiation therapy, immunotherapy, and cancer treatment
42 scientific and technological research services in the fields of medicine, biotechnology, and pharmaceuticals; scientific and technological research and drug development in the fields of cancer, pain, mental health disorders, cancer related distress, anxiety, depression and post-traumatic stress disorder; product development of pharmaceutical substances and medicines; pharmaceutical and medical research and development; pharmaceutical testing services; scientific laboratory services; research laboratory services relating to medicine, biotechnology, and pharmaceuticals; providing online non-downloadable software for data analytics, machine learning, knowledge management, and predictive analysis of biostatistical and treatment data in the field of medical research
Aug 23, 2023
Abandonment Notice E-Mailed - Inter Partes Decision
Aug 23, 2023
Abandonment - After Inter Partes Decision
Aug 23, 2023
Opposition Terminated No. 999999
Aug 23, 2023
Opposition Sustained No. 999999
Jun 15, 2023
Opposition Instituted No. 999999
Mar 20, 2023
Extension Of Time To Oppose Received
Feb 21, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 21, 2023
Published For Opposition
Feb 1, 2023
Notification Of Notice Of Publication E-Mailed
Jan 18, 2023
Approved For Pub - Principal Register
Jan 17, 2023
Examiner's Amendment Entered
Jan 17, 2023
Notification Of Examiners Amendment E-Mailed
Jan 17, 2023
Examiners Amendment E-Mailed
Jan 17, 2023
Examiners Amendment -Written
Jan 6, 2023
Teas/Email Correspondence Entered
Jan 5, 2023
Correspondence Received In Law Office
Jan 5, 2023
Teas Response To Office Action Received
Oct 5, 2022
Automatic Update Of Assignment Of Ownership
Jul 16, 2022
Notification Of Non-Final Action E-Mailed
Jul 16, 2022
Non-Final Action E-Mailed
Jul 16, 2022
Non-Final Action Written
Jul 11, 2022
Assigned To Examiner
Jan 28, 2022
New Application Office Supplied Data Entered
Jan 27, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
